What is it about?

The review article discusses the emerging drugs for targeting mutant 53

Featured Image

Why is it important?

Mutant p53 is the most frequent genetic alteration in cancer. It was previously believed to be undruggable. However, in recent years, several compounds have been described that can reactivate mutant p53 to an active form. These compounds are discussed in this Review

Read the Original

This page is a summary of: Mutant p53 as a target for cancer treatment, European Journal of Cancer, September 2017, Elsevier,
DOI: 10.1016/j.ejca.2017.06.023.
You can read the full text:

Read

Contributors

The following have contributed to this page